Circulating prostasin associates with presence and severity of idiopathic pulmonary fibrosis (IPF)

被引：0
|
作者：
Todd, Jamie [1 ,2 ]
Mulder, Hillary [1 ]
Neely, Megan L. [1 ,2 ]
Belperio, John A. [3 ]
Lasky, Joseph A. [4 ]
Luckhardt, Tracy R. [5 ]
Palmer, Scott M. [1 ,2 ]
Hesslinger, Christian [6 ]
Schlange, Thomas [6 ]
Leonard, Thomas B. [7 ]
机构：
[1] Duke Clin Res Inst, Durham, NC USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] UCLA, David Geffen Sch Med, Los Angeles, CA USA
[4] Tulane Univ, Sch Med, New Orleans, LA 70112 USA
[5] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA
[6] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
[7] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA1144
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Circulating Prostasin: An Independent Risk Marker in Idiopathic Pulmonary Fibrosis (IPF)
    Todd, J. L.
    Page, C.
    Wu, P.
    Belperio, J. A.
    Maher, T. M.
    Palmer, S. M.
    Leonard, T. B.
    Hesslinger, C.
    Neely, M. L.
    Schlange, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [2] The circulating metabolome in idiopathic pulmonary fibrosis (IPF)
    Hesslinger, Christian
    Overton, Robert
    Keller, Sascha
    Neely, Megan L.
    Belperio, John A.
    Vinisko, Richard
    Leonard, Thomas
    Flaherty, Kevin R.
    Noth, Imre
    Palmer, Scott M.
    Todd, Jamie L.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [3] Idiopathic Pulmonary Fibrosis (IPF): An Overview
    Barratt, Shaney L.
    Creamer, Andrew
    Hayton, Conal
    Chaudhuri, Nazia
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (08)
  • [4] Sleep and idiopathic pulmonary fibrosis (IPF)
    Rasche, Kurt
    Leidag, Markus
    Orth, Maritta
    SOMNOLOGIE, 2020, 24 (01): : 11 - 15
  • [5] TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS (IPF)
    FULMER, J
    ELSON, N
    GAL, EV
    MCLEES, B
    DEMETS, D
    WEINBERGER, S
    KELMAN, J
    CRYSTAL, R
    CLINICAL RESEARCH, 1978, 26 (03): : A538 - A538
  • [6] Outcomes of Antifibrotic Treatment in Idiopathic Pulmonary Fibrosis (IPF) Patients with Circulating Autoantibodies
    Smith, A.
    Ding, G.
    Kropski, J.
    Mason, W.
    Lancaster, L. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [7] DISEASE SEVERITY AND QUALITY OF LIFE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): AN ANALYSIS OF THE IPF-PRO REGISTRY
    O'Brien, Emily
    Hellkamp, Anne
    Neely, Megan
    Swaminathan, Aparna
    Bender, Shaun
    Snyder, Laurie
    Culver, Daniel
    Conoscenti, Craig
    Todd, Jamie
    Palmer, Scott
    Leonard, Thomas
    CHEST, 2019, 156 (04) : 1580A - 1581A
  • [8] Association of Circulating Metabolites With Disease Severity and Mortality in Patients With Idiopathic Pulmonary Fibrosis: Data From the IPF-PRO Registry
    Summer, R. S.
    Todd, J. L.
    Neely, M. L.
    Lobo, L.
    Namen, A. M.
    Newby, L.
    Shafazand, S.
    Suliman, S.
    Hesslinger, C.
    Keller, S.
    Leonard, T. B.
    Palmer, S. M.
    Ilkayeva, O.
    Muehlbauer, M. J.
    Newgard, C. B.
    Roman, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [9] Idiopathic pulmonary fibrosis (IPF) and gastroeosophageal disorders
    Kokeza, Josipa
    Mise, Kornelija
    Puljiz, Zeljko
    Bradaric, Anteo
    Lozo, Emilija
    Mise, Josko
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [10] Idiopathic pulmonary fibrosis (IPF): the patient journey
    Cottin, Vincent
    Bonella, Francesco
    Small, Mark
    Siddall, James
    Langley, Jonathan
    Inoue, Yoshikazu
    Lancaster, Lisa
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
12345